InsiderPulse| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-27 | 2026-03-30 | George Jeffrey P. | Director | Purchase | 5,592 | $8.92 | $50K | 5,592 | View ↗ | |
| 2026-03-27 | 2026-03-30 | Schimmelpennink Evert B. | Director & President, CEO and Secretary | Purchase | 28.1K | $8.95 | $251K | 77.3K | View ↗ | |
| 2026-03-27 | 2026-03-30 | Chevallard Daniel R. | Chief Financial Officer | Purchase | 7,500 | $8.57 | $64K | 12.9K | View ↗ |
No annual data found.
Quant snapshot: Beachbody, Deutsche Telekom among top-rated names as IceCure Medical, Fold Holdings lag
LENZ Therapeutics to Report First Quarter 2026 Financial Results and Recent Corporate Highlights on May 11, 2026 and Attend Upcoming Investor Conference
William Blair updates conviction stock list
LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdom